We had already shown that PGE2 was decreased in Gdpd3−/− CML BM cells compared to Gdpd3+/+ CML BM cells (Fig. 4a). This evidence concerns the gene GDPD3 and chronic myelogenous leukemia, BCR-ABL1 positive.